MannKind to Present at Aegis Capital Corp. 2015 Growth Conference
October 05 2015 - 9:00AM
MannKind Corporation (Nasdaq:MNKD), focused on discovering,
developing and commercializing therapeutic products for diabetes,
announced today that it will present at the Aegis Capital Corp.
2015 Growth Conference on Thursday, October 8, 2015 at 9:30 am
Pacific Time at the Encore at the Wynn Hotel in Las Vegas, Nevada.
Interested parties can access a link to the live webcast of the
presentations from the News & Events section of the Company's
website at http://www.mannkindcorp.com.
About MannKind Corporation
MannKind Corporation (Nasdaq:MNKD) focuses on the discovery,
development and commercialization of therapeutic products for
patients with diseases such as diabetes. MannKind maintains a
website at http://www.mannkindcorp.com to which MannKind regularly
posts copies of its press releases as well as additional
information about MannKind. Interested persons can subscribe on the
MannKind website to e-mail alerts that are sent automatically when
MannKind issues press releases, files its reports with the
Securities and Exchange Commission or posts certain other
information to the website.
CONTACT: Company Contact:
MannKind Corporation
Matthew J. Pfeffer
Corporate Vice President and
Chief Financial Officer
661-775-5300
mpfeffer@mannkindcorp.com
MannKind (NASDAQ:MNKD)
Historical Stock Chart
From Mar 2024 to Apr 2024
MannKind (NASDAQ:MNKD)
Historical Stock Chart
From Apr 2023 to Apr 2024